The Fogarty Institute for Innovation is proud to continue to strengthen its presence in women”s healthcare innovation, with the addition of three new startups, which have joined the organization as new companies-in-residence: Igantia Therapeutics, Marz Medical and Madorra.
Each of the companies are working on technologies that will address unmet healthcare needs that afflict aging women and millions of female cancer patients. The Institute now has seven in-residence startups focused on women and infant healthcare issues.
“Women’s health has historically been underdeveloped and underfunded in terms of medical innovation, yet it offers an opportunity to revolutionize patient care globally,” said Ann Fyfe, President and CEO of the Fogarty Institute for Innovation. “We are excited to not only increase the number of medical technologies aimed at helping women, but also delighted to support more women leaders in this industry.”